Literature DB >> 6248589

Serum 21-deoxycortisol and 17-hydroxypregnenolone in parents of patients with congenital adrenal hyperplasia.

F Cassorla, A Tenore, J S Parks, J Marino, A M Bongiovanni.   

Abstract

The response of serum 21-deoxycortisol (21-DF), 17-hydroxypregnenolone (17-OHPE), 11-deoxycortisol and cortisol to iv ACTH, was compared in 14 adult controls ane and post stimulation concentrations of hormones were similar in controls and parents, except for those of 21-DF, which were significantly greater in heterozygotes 30 min (p less than 0.005), 60 min (p less than .0025) and 90 min (p less than 0.005) after stimulation with ACTH. When rates of increase were determined, those of 21-DF at 30, 60 and 90 min were significantly higher in the parents. Sixteen of the 26 parents (62%) had a rate of increase of 21-DF from 0 to 60 min greater than the mean plus two standard deviations of the control group. Using this same criteria, 11 of the 13 mothers (85%) of affected children could be identified as heterozygotes. The rate of increase of 21-DF from 0 to 60 min following ACTH provides a method for the detection of some heterozygote carriers of congenital adrenal hyperplasia and may be useful particularly in the identification of female carriers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248589     DOI: 10.1007/BF03348240

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  [On the genetics of the congenital adrenogenital syndrome (virilizing adrenal hyperplasia)].

Authors:  A PRADER; G J ANDERS; H HABICH
Journal:  Helv Paediatr Acta       Date:  1962

2.  Response to an 11beta-hydroxylase inhibitor (SU-4885) in males with adrenal hyperplasia and in their parents.

Authors:  W W CLEVELAND; M NIKEZIC; C J MIGEON
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

3.  Evidence for partial 21-hydroxylase deficiency among heterozygote carriers of congenital adrenal hyperplasia.

Authors:  P A Lee; J F Gareis
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

4.  Studies on the pattern of circulating steroids in the normal menstrual cycle. 2. Levels of 20alpha-dihydroprogesterone, 17-hydroxy-progesterone and 17-hydroxypregnenolone and the assessment of their value for ovulation prediction.

Authors:  A R Aedo; B M Landgren; Z Cekan; E Diczfalusy
Journal:  Acta Endocrinol (Copenh)       Date:  1976-07

5.  Simplified assessment of pituitary-adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone.

Authors:  R F Spark
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

6.  Plasma 17-OH-pregnenolone in normal subjects.

Authors:  T J McKenna; D L DiPietro; R D Brown; C A Strott; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

7.  A study of the parents of patients with congenital adrenal hyperplasia: detection of the heterozygote.

Authors:  R Hall; P A Smith; R A Harkness; G A Smart
Journal:  Proc R Soc Med       Date:  1970-10

8.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

9.  Steroid studies in parents of patients with congenital virilizing adrenal hyperplasia.

Authors:  Q H Qazi; J G Hill; M W Thompson
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

10.  Radioligand assay for 5 -3 -hydroxysteroids. II. 5-Androstene-3 ,17 -diol and 3 ,17 -dihydroxy-5-pregnen-20-one.

Authors:  D L Loriaux; M B Lipsett
Journal:  Steroids       Date:  1972-05       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.